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Abstract
In public health and medical research, ratio measures of percent change relative to baseline are 
often used to express a change in disease incidence. Estimating variance becomes more complex 
when the comparison is to an expectation based on previous data (E), rather than to an observed 
value (O). In 2009, the decline in reported tuberculosis (TB) cases was the largest single-year 
decrease since national TB surveillance began in 1953. To investigate the 2009 TB decline 
compared with expected counts, we analyzed TB cases reported to the Center for Disease Control 
and Prevention’s National Tuberculosis Surveillance System. We log-transformed case counts for 
2000–2008, and performed linear regression stratified by patient and clinical characteristics. We 
calculated relative declines from expectation as (O−E)/E for patient subgroups, and constructed 
95% confidence intervals for TB declines. We then formulated a Z-score test statistic comparing 
declines across patient subgroups under the null hypothesis that the difference of the two ratio 
measures was zero. We illustrate our methods by comparing 2009 declines from expectation for 
US-born versus foreign-born patients. Predicted values and confidence intervals assessed the 
magnitude of unexpected TB declines within patient groups, while statistical tests comparing ratio 
measures evaluated relative TB declines across groups.
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1. Introduction
In public health and medical research, measures of percent change relative to baseline are 
often used to express a change in disease incidence, for instance, an increase in disease 
because of exposure to an infectious agent, or decrease in disease because of a clinical 
intervention or public health campaign [1–3]. Time is a key predictor for such analyses. The 
baseline incidence of disease is measured or assumed to be known for comparison with 
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increasing or decreasing incidence over time. Variance of the appropriate baseline disease 
incidence measure is calculated based on sample or population data.
Estimating variance for relative change measures becomes more complex when the 
comparison is to an expectation based on previous data, rather than to an observed value. In 
2009, the decline in reported tuberculosis (TB) cases was the largest single-year decrease 
since national TB surveillance began in 1953. To investigate the 2009 decline compared 
with expected counts, we analyzed TB cases reported to the Center for Disease Control and 
Prevention (CDC) National Tuberculosis Surveillance System.
2. Estimation of percent change without accounting for trends
Since 1953, US reporting areas have submitted information on incident TB cases to the 
CDC’s National Tuberculosis Surveillance System [4]. Individual case-report data, 
including characteristics on TB patient country of origin, have been reported to the National 
Tuberculosis Surveillance System since 1993. In 1993, 29% of TB cases diagnosed in the 
United States were foreign-born. The proportion of TB cases among foreign-born persons 
has steadily grown, to 59% in 2009 [4].
The incidence of TB has declined among both US-born and foreign-born persons since 
1993; however, TB declines among the foreign-born have been less substantial than among 
the US-born. While global TB control has led to incidence declines worldwide [5], TB 
infection prevalence remains high in many countries from which persons diagnosed with TB 
disease in the United States emigrate. Risk of progression from latent infection to TB 
disease remains high among foreign-born persons, even after more than five years since US 
arrival [6].
In the United States, TB case counts in 2009 were the lowest since national reporting began, 
showing the greatest single-year decrease ever. Although case counts declined an average of 
425 cases per year since 2000, the observed decline in 2009 was 1361 cases fewer than in 
2008 [4]. The decline in TB case counts was reported as a 14.8% decrease for US-born 
persons and 10.5% decrease for foreign-born persons [7]. In the next section, we compare 
the relative decrease in US-born and foreign-born cases, accounting for prior TB trends 
(Figure 1; data publicly available at http://www.cdc.gov/tb/statistics/reports/2009/table5.htm 
[Accessed 9/13/2011]).
3. Methods: percent change accounting for trends
We log-transformed observed case counts for 2000–2008, and performed linear regression 
(overall R2 = 0:99) to calculate predicted values for 2009 counts. For US-born and foreign-
born subgroups, we compared the observed count in 2009 to the expected value based on 
prediction. We reported the relative decline of observed counts in 2009 (O) from expected 
values (E) as a percent change by multiplying (O − E)/E by 100. We constructed 95% 
confidence intervals around percent declines by patient sub- group. We then formulated a 
hypothesis test for the difference of the relative declines in TB cases among US-born and 
foreign-born persons. We constructed a Wald test statistic [8] for the null hypothesis that the 
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difference in relative TB declines between US-born and foreign-born persons in 2009 was 
zero.
4. Model for decline in cases and formulation of test statistic
For both the US-born and foreign-born populations, we constructed a linear regression 
model for log cases from 2000–2008 and assumed a Poisson distribution of cases in 2009. 
Specifically, with Yij denoting counts,
where x0 = 2000, … x8 = 2008, and index i refers to US-born (i = 0) or foreign-born (i = 1). 
Within each population, the error terms are normally distributed with zero mean and 
common variance . The parameters of interest are the relative declines in cases, where x9 = 
2009
For brevity, we denote the observed count for 2009 by Oi = Yi9 and the predicted count for 
2009, based on regression estimates for 2000–2008 data, by , 
where the  terms denote the regression-based maximum likelihood estimators (MLEs). 
Then Oi and Ei are statistically independent and are distributed as
where xi =(1, xi)T and X is the 9×2 design matrix with rows , i = 0, …, 8. Approximate 
normality of Oi results from the normal approximation for a Poisson distribution with large 
mean (case counts ~ 103). The MLEs of Δi are (Oi − Ei)/Ei.
Confidence intervals (CI) for Δi at 100(1 − α)% level are obtained by inverting the Wald test 
statistic for Δi. These are given by
where  are the regression-based MLEs of the error variances .
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Similarly, the Wald test yields a Z-score test statistic for the difference of the relative 
percent declines Δ1 − Δ2
5. Results: percent change in TB cases by US and foreign origin of birth
Among the US-born, the observed count of 4571 TB cases was compared with an expected 
4918, for a difference of 347 fewer cases than expected in 2009. Among foreign-born 
persons, the observed count of 6854 cases in 2009 was 855 fewer cases than the expected 
7709 count.
We calculated the relative decline from expected case counts, (O − E)/E, by TB patient 
origin. Estimated percent declines and 95% confidence intervals for the US-born and 
foreign-born were −7.1% (−11.4, −2.8) and −11.1% (−14.7, −7.4), respectively. We 
calculated the Z-test statistic comparing US-born and foreign-born relative declines from 
expected as Z = 1.66 (p = 0.10).
6. Discussion
Because predicted values were obtained from regression rather than a known population 
estimate, we were unable to use typical variance calculations for observed compared with 
expected, sometimes described as standardized morbidity or mortality ratios [9]. In the case 
of standardized mortality ratios, the expected count is calculated from such a large sample, 
or from a complete population census, as to have no variance. The observed value is then 
assumed for variance calculations to be distributed as a Poisson random variable with 
parameter equal to the expected count. This assumption was inappropriate because our 
expected count, E, was a predicted value based on the random variable of observed counts, 
O; E has variability around its estimate. Instead, we calculated variance around O assuming 
a Poisson with parameter O, and used the log-transformed normal variance of E. To assess 
the robustness of our assumption, we examined the test statistics, which resulted when we 
used exact expressions for mean and variance from the log-normal distribution for E. 
Numerical differences were negligible; therefore, in the interests of simplicity, we chose to 
present Wald statistics.
Our example describes differences by TB patient country of origin. The magnitude of the 
foreign-born decline relative to expectation (855 cases) was more than twice the magnitude 
of the US-born decline (347 cases). This reflects the demographics of TB cases diagnosed in 
the United States, of whom almost 60% are foreign-born. However, percent declines relative 
to expectation were useful for standardizing across groups, to account for differences in TB 
trends. Accounting for 2000–2008 trends in declining TB incidence was valuable in 
comparison to interpreting declines comparing 2009 to 2008 cases only, because failure to 
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account for differences in trends yielded estimates of a 14.8% decrease among US- born 
persons and a 10.5% decrease among foreign-born persons in 2009, compared with 7.1% 
and 11.1% declines, respectively [7]. When analyzing deviation from the expected, the 
11.1% decline among the foreign-born was not significantly different from the 7.1% decline 
among the US-born; both patient strata by origin had significant declines in TB incidence in 
2009. Predicted values and confidence intervals evaluated the magnitude of unexpected TB 
declines within groups, while statistical tests of percent change relative to expected counts 
were used to compare groups.
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